Quality improvement in neurology: Mild cognitive impairment quality measurement set

Norman L. Foster; Mark W. Bondi; Rohit Das; Mary Foss; Linda A. Hershey; Steve Koh; Rebecca Logan; Carol Poole; Joseph W. Shega; Ajay Sood; Niranjan Thothala; Meredith Wicklund; Melissa Yu; Amy Bennett; David Wang

doi:10.1212/WNL.0000000000008259

Quality improvement in neurology: Mild cognitive impairment quality measurement set

Norman L. Foster, Mark W. Bondi, Rohit Das, Mary Foss, Linda A. Hershey, Steve Koh, Rebecca Logan, Carol Poole, Joseph W. Shega, Ajay Sood, Niranjan Thothala, Meredith Wicklund, Melissa Yu, Amy Bennett, David Wang

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	705-713
Number of pages	9
Journal	Neurology
Volume	93
Issue number	16
DOIs	https://doi.org/10.1212/WNL.0000000000008259
State	Published - Oct 15 2019

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000008259

Cite this

Quality improvement in neurology : Mild cognitive impairment quality measurement set. / Foster, Norman L.; Bondi, Mark W.; Das, Rohit; Foss, Mary; Hershey, Linda A.; Koh, Steve; Logan, Rebecca; Poole, Carol; Shega, Joseph W.; Sood, Ajay; Thothala, Niranjan; Wicklund, Meredith; Yu, Melissa; Bennett, Amy; Wang, David.

In: Neurology, Vol. 93, No. 16, 15.10.2019, p. 705-713.

Research output: Contribution to journal › Article › peer-review

Foster, Norman L. ; Bondi, Mark W. ; Das, Rohit ; Foss, Mary ; Hershey, Linda A. ; Koh, Steve ; Logan, Rebecca ; Poole, Carol ; Shega, Joseph W. ; Sood, Ajay ; Thothala, Niranjan ; Wicklund, Meredith ; Yu, Melissa ; Bennett, Amy ; Wang, David. / Quality improvement in neurology : Mild cognitive impairment quality measurement set. In: Neurology. 2019 ; Vol. 93, No. 16. pp. 705-713.

@article{ec0aedf3093948fe86318e9b9eb8256f,

title = "Quality improvement in neurology: Mild cognitive impairment quality measurement set",

author = "Foster, {Norman L.} and Bondi, {Mark W.} and Rohit Das and Mary Foss and Hershey, {Linda A.} and Steve Koh and Rebecca Logan and Carol Poole and Shega, {Joseph W.} and Ajay Sood and Niranjan Thothala and Meredith Wicklund and Melissa Yu and Amy Bennett and David Wang",

note = "Funding Information: N. Foster reports receiving grant support from the NIH, the June Morris Trust, and Rodney and Carolyn Brady Fund, and research funding from GE Health, AbbVie, Biogen, Suven, and Lilly Pharmaceuticals. Dr. Foster serves as a consultant for AbbVie and is CEO and co-owner of Proactive Memory Services, Inc. M. Bondi reports receiving grant support from the NIH, serving as a consultant for Eisai, Novartis, and Roche, and receiving royalties from Oxford University Press. R. Das reports research funding from Eisai, consulting with law firms and Neurotech EEG, and prior speakers{\textquoteright} bureau with LivaNova. M. Foss reports no disclosures relevant to the manuscript. L. Hershey reports she is author of the annual memory loss review for MedLink Neurology, has received royalties from MedLink Corporation and American College of Physicians, and has served on the Network of Experts for the FDA. S. Koh reports no disclosures relevant to the manuscript. R. Logan reports volunteering for the Alzheimer{\textquoteright}s Association and serving on their Speakers Bureau and current participation in National Institute of Aging and Eli Lilly and Company research projects. C. Poole and J. Shega report no disclosures relevant to the manuscript. A. Sood has received research support from Takeda Inc, Roche, Merck, Eli Lilly, Neurotrope, Novartis, Eisai, Avanir, and Biogen; received compensation for talks for Piramal; and served as Site PI for IDEAS study. N. Thothala reports no disclosures relevant to the manuscript. M. Wicklund receives research support from the Florida Department of Health Ed and Ethel Moore Alzheimer{\textquoteright}s Disease Research Program, IDEAS, and Novartis. M. Yu reports no disclosures relevant to the manuscript. Q. Bennett is an employee of the American Academy of Neurology. D. Wang reports no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.",

year = "2019",

month = oct,

day = "15",

doi = "10.1212/WNL.0000000000008259",

language = "English (US)",

volume = "93",

pages = "705--713",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Quality improvement in neurology

T2 - Mild cognitive impairment quality measurement set

AU - Foster, Norman L.

AU - Bondi, Mark W.

AU - Das, Rohit

AU - Foss, Mary

AU - Hershey, Linda A.

AU - Koh, Steve

AU - Logan, Rebecca

AU - Poole, Carol

AU - Shega, Joseph W.

AU - Sood, Ajay

AU - Thothala, Niranjan

AU - Wicklund, Meredith

AU - Yu, Melissa

AU - Bennett, Amy

AU - Wang, David

N1 - Funding Information: N. Foster reports receiving grant support from the NIH, the June Morris Trust, and Rodney and Carolyn Brady Fund, and research funding from GE Health, AbbVie, Biogen, Suven, and Lilly Pharmaceuticals. Dr. Foster serves as a consultant for AbbVie and is CEO and co-owner of Proactive Memory Services, Inc. M. Bondi reports receiving grant support from the NIH, serving as a consultant for Eisai, Novartis, and Roche, and receiving royalties from Oxford University Press. R. Das reports research funding from Eisai, consulting with law firms and Neurotech EEG, and prior speakers’ bureau with LivaNova. M. Foss reports no disclosures relevant to the manuscript. L. Hershey reports she is author of the annual memory loss review for MedLink Neurology, has received royalties from MedLink Corporation and American College of Physicians, and has served on the Network of Experts for the FDA. S. Koh reports no disclosures relevant to the manuscript. R. Logan reports volunteering for the Alzheimer’s Association and serving on their Speakers Bureau and current participation in National Institute of Aging and Eli Lilly and Company research projects. C. Poole and J. Shega report no disclosures relevant to the manuscript. A. Sood has received research support from Takeda Inc, Roche, Merck, Eli Lilly, Neurotrope, Novartis, Eisai, Avanir, and Biogen; received compensation for talks for Piramal; and served as Site PI for IDEAS study. N. Thothala reports no disclosures relevant to the manuscript. M. Wicklund receives research support from the Florida Department of Health Ed and Ethel Moore Alzheimer’s Disease Research Program, IDEAS, and Novartis. M. Yu reports no disclosures relevant to the manuscript. Q. Bennett is an employee of the American Academy of Neurology. D. Wang reports no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

PY - 2019/10/15

Y1 - 2019/10/15

UR - http://www.scopus.com/inward/record.url?scp=85073184410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073184410&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000008259

DO - 10.1212/WNL.0000000000008259

M3 - Article

C2 - 31534026

AN - SCOPUS:85073184410

VL - 93

SP - 705

EP - 713

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 16

ER -

Quality improvement in neurology: Mild cognitive impairment quality measurement set

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this